Pregnancy-associated plasma protein-A (PAPP-A) levels in patients with severe allergic asthma are reduced by omalizumab

Sadeleştirilmiş öğe sayfası
dc.contributor.authorBulut, Ismet
dc.contributor.authorOzseker, Zeynep F.
dc.contributor.authorCoskun, Abdurrahman
dc.contributor.authorSerteser, Mustafa
dc.contributor.authorUnsal, Ibrahim
dc.date.accessioned2025-10-16T15:26:04Z
dc.date.issued2018
dc.identifier.doi10.1080/02770903.2017.1396471
dc.identifier.otherWOS:000454846800010
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8339
dc.publisherTAYLOR \& FRANCIS LTD
dc.sourceJOURNAL OF ASTHMA
dc.subjectAllergy
dc.subjectasthma
dc.subjectinflammation
dc.subjectomalizumab
dc.subjectpregnancy\\-associated plasma protein A
dc.titlePregnancy-associated plasma protein-A (PAPP-A) levels in patients with severe allergic asthma are reduced by omalizumab
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS